Clofarex clofarabine: Phase I data

In a U.S. Phase I trial in 30 patients, 7 of the 20 evaluable patients had stable disease. Also, 1 patient with prostate cancer had a decrease in PSA levels to 934 ng/ml from 7975 ng/ml at baseline. D...